Professional Documents
Culture Documents
Introduction: The aim of this prospective clinical study was to evaluate the skeletal, dentoalveolar, and softtissue effects of maxillary protraction with miniplates compared with conventional facemask therapy and an
untreated Class III control group. Methods: Forty-ve subjects who were in prepubertal or pubertal skeletal
growth periods were included in the study and divided into 3 groups of 15 patients each. All subjects had skeletal
and dental Class III malocclusions with maxillary deciency, vertically normal growth pattern, anterior crossbite,
Angle Class III molar relationship, normal or increased overbite, and retrusive nasomaxillary complex. Before
maxillary protraction, rapid maxillary expansion with a bonded appliance was performed in both treatment
groups. In the rst group (MP1FM), consisting of 5 girls ande 10 boys (mean age, 10.91 years), facemasks
were applied from 2 titanium miniplates surgically placed laterally to the apertura piriformis regions of the maxilla.
The second group (FM) of 7 girls and 8 boys (mean age, 10.31 years) received maxillary protraction therapy with
conventional facemasks applied from hooks of the rapid maxillary expansion appliance. The third group of 8 girls
and 7 boys (mean age, 10.05 years) was the untreated control group. Lateral cephalometric lms were obtained
at the beginning and end of treatment or observation in all groups and analyzed according to a structural superimposition method. Measurements were evaulated statistically with Wilcoxon and Kruskal-Wallis tests. Results:
Treatment periods were 6.78 and 9.45 months in the MP1FM and FM groups, respectively, and the observation
period in the control group was 7.59 months. The differences were signicant between the 3 groups (P \0.05)
and the MP1FM and FM groups (P \0.001). The maxilla moved forward for 2.3 mm in the MP1FM group and
1.83 mm in the FM group with maxillary protraction. The difference was signicant between 2 groups (P\0.001).
The protraction rates were 0.45 mm per month in the MP1FM group and 0.24 mm per month in the FM group
(P \0.001). The maxilla showed anterior rotation after facemask therapy in the FM group (P \0.01); there
was no signicant rotation in the MP1FM group. Posterior rotation of the mandible and increased facial height
were more evident in the FM group compared with the MP1FM group (P \0.01). Both the maxilla and the mandible moved forward signicantly in the control group. Protrusion and mesialization of the maxillary teeth in the
FM group were eliminated in the MP1FM group. The maxillomandibular relationships and the soft-tissue prole
were improved remarkably in both treatment groups. Conclusions: The undesired effects of conventional
facemask therapy were reduced or eliminated with miniplate anchorage, and efcient maxillary protraction
was achieved in a shorter treatment period. (Am J Orthod Dentofacial Orthop 2011;139:636-49)
636
Sar et al
growth can contribute to the treatment of Class III malocclusion.11-15 The principle of maxillary protraction is
to apply an anteriorly directed force on the
circummaxillary sutures, which are still patent at an
early age and thereby stimulate bone apposition in the
suture areas.
A tooth-borne device bonded to the maxillary teeth is
the point of force application, and the forehead and the
chin are the anchorage sources for protraction in facemask theapy. The effects of maxillary protraction include
anterior movement of the maxilla and the maxillary
dentition, accompanied by counterclockwise rotation,
lingual inclination of the mandibular teeth, and clockwise rotation of the mandible, causing the chin to
move downward and backward. Lower anterior facial
height increases while overbite decreases.16-23 These
effects tend to turn a Class III malocclusion into
a Class I malocclusion and produce an orthognathic
prole in a short time. However, indirect application of
force limits the potential for orthopedic change and
inevitably causes undesirable tooth movements such as
mesial movement and extrusion of the maxillary
molars and labial tipping of the maxillary incisors.
There is a need for a stable anchorage to transfer the
force directly to the circummaxillary sutures, thus
eliminating the undesirable dental effects and obtaining
major skeletal effects. Orthopedic anchorage for maxillary
protraction is a new area of research, and investigations on
this subject are limited. Ankylosed tooth, osseointegrated
implants, titanium screws, and onplants have been used as
stable anchorage in previous case reports.24-27 Titanium
miniplates have been shown to provide absolute
anchorage when orthopedic forces were applied with
facemasks in some clinical studies.28-32
To date, however, there is a lack of knowledge on the
comparative effects of maxillary protraction with or
without skeletal anchorage. Since there is no study in
the literature, in this prospective study, we attempted
to evaluate the skeletal, dentoalveolar, and soft-tissue
effects of maxillary protraction with miniplates compared with conventional facemask therapy and an untreated Class III control group.
MATERIAL AND METHODS
Forty-ve subjects from the Department of Orthodontics, Faculty of Dentistry, University of Baskent in
Ankara, Turkey, were included in this study. All subjects
were between the PP2 5 and MP3cap developmental
stages at the beginning of the treatment or the control
period according to their hand-wrist radiographs.33
The patients were selected by the following inclusion criteria: (1) skeletal and dental Class III malocclusion with
maxillary deciency (ANB, \0 ; Nperp-A, \1 mm;
637
Sar et al
638
Fig 1. A, Mucoperiosteal incisions made at the labial vestibule of the maxilla on both sides; B and C,
adaptation and xation of miniplates to lateral nasal walls of the maxilla; D, sutures exposing the third
hole into the oral cavity before maxillary protraction.
Sar et al
639
Fig 2. A, Intraoral view of the miniplates placed laterally to the apertura piriformis; B, extraoral frontal
view of the application of a facemask via miniplates; C, prole view of the patient with a facemask.
Statistical analysis was performed by using the Statistical Package for Social Sciences (version 13.0, SPSS,
Chicago, Ill). The normality of the distribution of the variables was checked by using the Shapiro-Wilks test and
the homogeneities of the group variances by the Levene
Sar et al
640
Fig 3. Maxillary and maxillomandibular skeletal measurements used in the study: 1, SNA ( ); 2, HR-ANS
(mm); 3, HR-PNS (mm); 4, HR.PP ( ); 5, Cd-A (mm);
6, A-VR (mm); 7, Nperp-A (mm); 8, ANB ( ); 9, (A-VR)(B-VR) (mm); 10, Wits (mm).
Sar et al
641
Sar et al
642
to be started at earlier ages to achieve more skeletal effects,11,14,16,37,38 whereas studies comparing the effects
of maxillary protraction applied in different skeletal
developmental stages reported similar skeletal
responses.39,40 Since this study was prospective, all
groups were homogeneous and similar with regard to
skeletal pattern, skeletal development, and chronologic
age before treatment. Only patients having
congenitally missing teeth and early loss of deciduous
posterior teeth in the mixed dentition stage were
included in the rst group.No signicant differences
were noted for any variables at T1.
RME with a bonded appliance was performed in both
treatment groups. RME has been advocated as a routine
part of facemask therapy in the correction of Class III
malocclusions even in the absence of maxillary constriction.41,42 RME expands a narrow maxilla, corrects
a posterior crossbite, increases arch length, and splints
the maxillary dentition during protraction therapy.
Additionaly, RME can disarticulate circummaxillary
sutures to facilitate the forward movement of the
maxilla via facemask therapy and lead to downward
and forward movement of A-point by approximately
1 mm.4143
In the MP1FM group, titanium miniplates were
preferred to be placed laterally to the apertura piriformis
region on both sides of the maxilla with 2 miniscrews.
Since the miniplates were xed with monocortical miniscrews, there was no need to wait for osseointegration.
This might be the major advantage of miniplate anchorage compared with osseointegrated implants and
onplants. In addition, they can be bent easily and withstand orthopedic forces. One main reason for choosing
a placement site laterally to the apertura piriformis regions of the maxilla was to apply protraction forces as
close as possible to the center of resistance (CR) of the
nasomaxillary complex. Because it is anterior to the circummaxillary sutures, the apertura piriformis was also
preferred for stimulating downward and forward
growth of the maxilla, which grows parallel to the force
vector.
The major complications for the MP1FM group were
mobility and inammation during protraction. Two of
the 30 miniplates were replaced during treatment because of their instability. The placement site was near
the apical region of the lateral incisors and erupting canines; thus, the possible reason for the mobility might
have been the quantity of cortical bone area in patients
with erupting canines. To prevent this complication, applying miniplates to the zygomatic buttress could be an
alternative in patients with erupting canines. The other
possible reasons for mobility might have been the application of an opposite force vector to the direction of
placement of the screws and the patients poor oral hygiene.
It was reported in many clinical studies that applying
the force vector between the lateral incisor and the
canine with a direction of 30 to 45 might help to decrease the amount of counterclockwise rotation of the
maxilla.4447 Despite modifying the location (molars,
premolars, canines) and the direction of the force
vector, anterior rotation of the maxilla could not be
prevented in conventional facemask applications. The
protraction forces applied from the level of the
Sar et al
643
Table I. Mean values of measurements at T1 and comparison of groups with the Kruskal-Wallis and Dunn tests
Parameter
Chronologic age (y)
Maxillary skeletal parameters
SNA ( )
A-VR (mm)
Cd-A (mm)
NPerp-A (mm)
HR-ANS (mm)
HR-PNS (mm)
HR.PP ( )
Mandibular skeletal parameters
SNB ( )
B-VR (mm)
Cd-Gn (mm)
NPerp-Pg (mm)
Pg-VR (mm)
SN.GoGn ( )
HR.GoMe ( )
BaNa.PtGn ( )
Facial heights
S-Go (mm)
N-Me (mm)
ANS-Me (mm)
N-ANS (mm)
S-Go/N-Me
Maxillomandibular parameters
ANB ( )
(A-VR)-(B-VR) (mm)
Wits (mm)
Dentoalveolar parameters
Overjet (mm)
MP 1 FM
FM
Control
Mean 6 SD
Mean 6 SD
Mean 6 SD
Median (range)
10.91 6 1.22
11.30 (9.00-12.30)
Median (range)
10.31 6 1.52
10.50 (8.50-13.10)
Median (range)
10.05 6 1.14
10.08 (8.50-12.08)
P
NS
77.86 6 3.14
77.50 (73.00-82.50)
60.60 6 3.19
60.50 (55.00-66.50)
80.80 6 3.86
80.50 (72.50-87.50)
4.36 6 3.44
4.50 (11-1.50)
43.13 6 3.57
42.00 (38.50-50.50)
41.90 6 3.31
41.50 (36.00-49.00)
1.53 6 4.18
2.00 (10.00-6.50)
77.86 6 2.72
79.00 (71.50-81.00)
60.40 6 3.60
59.50 (52.00-66.00)
79.50 6 3.87
80.00 (72.50-86.50)
4.53 6 2.92
5.00 (10-0.50)
41.36 6 2.53
42.00 (37.00-45.00)
40.43 6 2.28
40.00 (37.00-45.00)
1.13 6 3.55
1.00 (6.00-8.00)
78.63 6 2.43
78.50 (75.00-82.50)
60.83 6 2.49
60.50 (57.00-65.00)
78.90 6 4.12
78.00 (70.50-84.00)
3.56 6 2.27
3.50 (7.00-0)
41.80 6 2.92
42.00 (36.00-46.00)
40.90 6 2.29
40.00 (38.50-45.50)
1.03 6 2.68
2.00 (4.00-5.00)
NS
81.13 6 3.45
80.50 (75.50-87.50)
62.93 6 5.39
63.00 (52.00-72.00)
111.96 6 5.64
114.00 (100.0-120.0)
0.53 6 6.50
1.50 (17.00-11.00)
63.90 6 6.21
63.00 (53.50-74.00)
31.33 6 4.78
32.00 (22.00-38.00)
26.80 6 4.68
28.00 (18.00-34.00)
91.33 6 4.17
91.50 (84.00-99.00)
81.26 6 2.36
82.00 (75.50-85.00)
62.50 6 4.48
63.50 (49.50-67.00)
107.76 6 5.30
108.00 (101.0-116.5)
1.90 6 3.48
2.00 (7.50-3.00)
63.23 6 5.59
65.00 (48.00-69.50)
30.63 6 4.98
30.00 (23.00-38.00)
26.00 6 4.98
26.00 (18.00-33.00)
91.86 6 4.84
92.00 (83.00-101.5)
82.14 6 2.78
82.00 (78.00-87.50)
63.86 6 4.18
63.00 (57.00-71.50)
108.30 6 6.30
107.50 (99.0-118.0)
0.63 6 5.09
0.50 (12.50-8.00)
64.30 6 4.88
65.00 (56.50-72.00)
31.23 6 4.59
31.00 (24.50-38.50)
26.46 6 4.73
26.00 (19.00-34.00)
91.40 6 4.26
93.00 (81.50-96.00)
NS
71.36 6 4.84
72.00 (64.00-80.00)
111.03 6 6.64
111.00 (100.0-122.5)
59.83 6 4.55
61.00 (52.00-69.00)
51.20 6 3.64
50.00 (46.50-59.50)
0.63 6 0.03
0.63 (0.56-0.71)
69.53 6 4.03
70.00 (62.50-76.50)
108.50 6 6.10
108.00 (100.0-118.5)
58.63 6 4.20
58.00 (52.00-65.00)
49.86 6 2.91
50.50 (45.00-54.00)
0.63 6 0.04
0.63 (0.54-0.70)
68.96 6 3.35
69.00 (63.00-74.50)
108.83 6 5.96
110.00 (99.0-117.0)
58.66 6 4.02
60.00 (53.00-67.00)
50.16 6 3.06
50.50 (44.00-54.00)
0.63 6 0.03
0.62 (0.56-0.70)
NS
3.26 6 2.17
3.5 (8.00- 1.00)
2.33 6 3.20
1.50 (7.00-3.00)
8.50 6 3.25
9.00 (13.00- 3.00)
3.40 6 2.35
2.50 (8.00-0.00)
2.10 6 3.02
1.50 (6.50-2.50)
7.36 6 2.08
8.00 (10.00- 2.50)
3.51 6 2.05
3.50 (7.00- 0.50)
3.03 6 3.33
3.50 (7.50-2.00)
8.83 6 3.09
8.00 (16.50- 5.50)
NS
3.06 6 1.42
3.50 (6.00- 1.00)
3.63 6 0.89
3.50 (5.00- 2.50)
3.63 6 1.80
3.00 (9.00- 2.00)
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
Sar et al
644
Table I. Continued
Parameter
Overbite (mm)
U1i-VRmx (mm)
U1i-HRmx (mm)
U1.HRmx ( )
U1.PP ( )
L1i-VRmd (mm)
L1.HR ( )
L1.MP ( )
U6-VRmx (mm)
U6-HRmx (mm)
Soft-tissue parameters
N0 -Me0 (mm)
Sn-Me0 (mm)
A0 -VR (mm)
B0 -VR (mm)
UL-VR (mm)
LL-VR (mm)
Pg0 -VR (mm)
MP 1 FM
FM
Control
Mean 6 SD
Mean 6 SD
Mean 6 SD
Median (range)
2.73 6 1.70
2.50 (0.00-5.50)
43.80 6 3.08
42.50 (40.00-51.00)
25.50 6 2.73
25.50 (20.00-31.00)
114.60 6 5.87
115.00 (105.0-126.0)
113.70 6 6.32
114.00 (104.0-125.0)
62.16 6 3.98
62.00 (54.50-68.50)
87.63 6 6.48
87.00 (76.00-101.00)
84.96 6 6.97
85.00 (72.00-100.00)
16.80 6 4.40
16.50 (11.00-24.50)
18.46 6 3.73
18.00 (11.00-23.00)
Median (range)
3.93 6 1.88
4.00 (0.50-7.00)
41.66 6 3.81
41.00 (34.50-50.00)
25.70 6 2.08
25.00 (23.00-29.50)
110.83 6 6.44
110.00 (102.0-126.0)
110.36 6 6.01
110.00 (102.0-124.5)
61.73 6 3.46
62.00 (53.00-67.00)
88.03 6 7.32
87.00 (78.00-103.50)
85.43 6 8.50
82.50 (74.00-103.50)
14.70 6 2.78
14.00 (10.50-20.00)
19.50 6 2.29
19.00 (16.00-24.00)
Median (range)
3.06 6 1.82
3.00 (0.00-7.00)
43.73 6 5.21
44.50 (31.00-51.00)
24.63 6 3.07
25.00 (17.50-29.00)
113.20 6 7.13
112.00 (102.50-128)
114.23 6 8.33
112.00 (101.0-128.0)
62.50 6 4.40
63.50 (54.00-68.50)
87.66 6 8.26
87.50 (73.00-100.00)
84.93 6 7.58
85.00 (73.00-97.00)
17.40 6 3.23
18.50 (10.00-22.00)
18.83 6 2.15
18.50 (15.50-23.00)
P
NS
118.46 6 7.50
119.00 (108.0-132.0)
63.46 6 5.65
64.00 (54.00-74.00)
75.93 6 3.90
77.00 (67.50-82.00)
73.70 6 5.74
73.00 (62.50-82.50)
78.60 6 4.87
78.50 (69.00-86.00)
80.20 6 5.57
80.00 (69.50-90.00)
75.66 6 6.62
75.00 (64.00-85.50)
115.40 6 5.73
114.00 (106.0-127.0)
61.86 6 3.58
61.00 (55.00-68.00)
75.26 6 3.46
74.50 (66.50-81.00)
72.66 6 5.05
74.00 (58.00-78.50)
77.90 6 3.89
78.00 (69.00-83.50)
79.56 6 4.47
80.00 (68.00-84.50)
74.76 6 6.42
76.50 (57.50-82.00)
116.80 6 6.80
116.00 (106.5-132.0)
63.00 6 4.75
63.00 (56.50-74.00)
76.06 6 3.05
74.50 (72.00-81.00)
74.86 6 4.47
73.50 (68.00-82.50)
78.93 6 3.76
78.50 (73.00-85.00)
80.90 6 4.13
80.50 (74.50-87.50)
76.76 6 5.58
79.00 (67.00-83.50)
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
One major objective of this study was to evaluate the effects of facemask therapy with skeletal anchorage comparatively with tooth anchorage on the forward movement of the
maxilla. The Point-A advancement of the maxilla has been
reported in many previous studies by using conventional
intraoral anchorage devices. Many investigators including
Mermigos et al48 (SNA angle, 11.8 ; A-point, 11.76
mm), Baik21 (SNA angle, 11.5 ; A-point, 12 mm), Ngan
et al45 (SNA angle, 11.4 ; A-point, 11.9 mm), Arman
et al17 (SNA angle, 11.83 ; A-point, 12.11 mm), and
Nartallo-Turley and Turley49 (SNA angle, 12.35 ,
A-point, 13.34 mm) demonstrated these ndings. In this
study, the forward movement of Point A was 2.16 mm,
and the increase in the SNA angle was 1.83 in the FM group.
Our results for this group agree with previous studies.
Sar et al
645
Table II. Changes in the groups, with the signicance of changes in each group (Wilcoxon test) and comparison of
Parameter
Treatment duration(y)
Protraction rate(mm/mo)
Maxillary skeletal parameters
SNA ( )
A-VR (mm)
Cd-A (mm)
NPerp-A (mm)
HR-ANS (mm)
HR-PNS (mm)
HR.PP ( )
MP 1 FM (1)
FM (2)
Control (3)
Mean 6 SD
Mean 6 SD
Mean 6 SD
Median (range)
0.56 6 0.16
0.50 (0.30-0.80)
0.45 6 0.20
0.41 (0.17-0.83)
P
z
2.53 6 1.24
2.00 (1.00-5.50)
2.83 6 0.93
3.00 (1.50-5.00)
3.26 6 1.82
3.00 (1.00-8.50)
2.53 6 1.31
2.00 (0.50-4.50)
0.66 6 1.24
0.50 (1.00-4.00)
1.50 6 0.65
1.50 (0.50-3.00)
0.91 6 1.82
1.00 (3.00-4.00)
y
y
y
*
y
NS
*
y
NS
y
y
*
y
*
NS
*
y
NS
*
y
y
Median (range)
0.78 6 0.26
0.80 (0.40-1.30)
0.24 6 0.18
0.20 (0.00-0.62)
P
z
1.83 6 1.33
2.00 (0.00-4.00)
2.16 6 1.38
2.00 (0.00-5.00)
1.80 6 1.70
1.50 (1.50-6.00)
1.76 6 1.36
1.50 (0.00-4.00)
1.00 6 0.98
1.00 (1.50-2.00)
2.24 6 1.19
2.00 (0.00-4.00)
1.63 6 1.51
1.00 (1.00-5.00)
2.30 6 1.23
2.50 (4.00-0.50)
3.03 6 1.92
3.50 (6.00-1.00)
0.43 6 2.15
0.50 (3.00-4.00)
2.90 6 3.97
2.50 (9.00-4.00)
3.36 6 2.51
3.50 (7.00-1.00)
3.06 6 2.07
3.00 (1.00-6.00)
2.76 6 1.98
2.50 (0.00-7.50)
3.13 6 2.48
3.00 (7.00-2.00)
2.80 6 2.23
3.00 (3.00-6.00)
1.23 6 1.98
1.00 (2.00-6.00)
4.63 6 1.96
4.00 (2.00-9.00)
3.96 6 1.74
4.00 (0.50-7.00)
0.70 6 1.29
0.50 (1.00-3.00)
0.01 6 0.01
0.01 (0.04-0.01)
4.20 6 1.96
5.00 (0.00-7.50)
5.06 6 2.16
5.00 (0.50-8.50)
y
y
y
y
y
y
y
y
NS
*
y
y
y
y
*
y
y
NS
y
y
y
Median (range)
0.63 6 0.10
0.60 (0.50-0.80)
0.05 6 0.08
0.05 (0.08-0.27)
P
z
0.26 6 0.53
0.00 (1.00-1.00)
0.44 6 0.69
0.50 (0.50-2.00)
0.80 6 0.95
1.00 (0.50-3.50)
0.30 6 0.59
0.00 (1.00-1.50)
0.94 6 0.91
0.50 (0.50-2.50)
0.80 6 0.84
0.50 (0.00-2.50)
0.20 6 1.19
0.00 (2.50-1.50)
0.65 6 0.65
0.50 (0.00-2.00)
1.23 6 1.27
1.50 (1.00-3.50)
1.86 6 1.12
2.00 (0.50-4.50)
0.96 6 1.66
0.50 (2.00-5.00)
1.93 6 1.32
2.00 (0.00-4.50)
0.40 6 0.87
0.00 (2.00-1.00)
0.03 6 0.83
0.00 (1.00-2.00)
0.53 6 0.81
0.00 (0.00-2.50)
0.20 6 1.42
0.00 (3.00-2.00)
1.06 6 1.29
1.00 (1.00-3.50)
0.83 6 1.01
1.00 (1.50-3.00)
0.10 6 0.91
0.00 (2.00-1.50)
0.76 6 0.86
0.50 (0.50-2.50)
0.00 6 0.01
0.01 (0.05-0.03)
0.38 6 0.71
0.30 (1.50-0.50)
0.78 6 1.22
0.50 (3.50-1.20)
1-2
2-3
1-3
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
Sar et al
646
Parameter
Wits (mm)
Dentoalveolar parameters
Overjet (mm)
Overbite (mm)
U1i-VRmx (mm)
U1i-HRmx (mm)
U1.HRmx ( )
U1.PP ( )
L1i-VRmd (mm)
L1.HRmd ( )
L1.MP ( )
U6-VRmx (mm)
U6-HRmx (mm)
Soft-tissue parameters
N0 -Me0 (mm)
Sn-Me0 (mm)
A0 -VR (mm)
B0 -VR (mm)
UL-VR (mm)
LL-VR (mm)
Pg0 -VR (mm)
MP 1 FM (1)
FM (2)
Control (3)
Mean 6 SD
Mean 6 SD
Mean 6 SD
Median (range)
Median (range)
Median (range)
5.43 6 1.69
5.00 (3.00-9.00)
6.56 6 2.88
7.00 (1.00-11.50)
0.53 6 1.14
0.50 (2.00-1.50)
7.66 6 1.61
8.00 (4.00-10.00)
0.33 6 2.17
0.50 (2.00-5.50)
0.30 6 1.37
0.00 (4.00-1.00)
0.66 6 0.97
0.50 (1.00-2.50)
2.36 6 3.54
1.50 (10.00-2.00)
0.83 6 3.95
1.00 (-12.00-4.00)
3.93 6 2.59
3.50 (10.00- 1.00)
7.16 6 3.12
7.00 (13.00-0.00)
7.83 6 3.51
7.00 (14.00- 2.00)
0.03 6 0.63
0.00 (1.50-1.00)
0.16 6 0.67
0.00 (1.00-1.50)
7.93 6 1.65
7.50 (5.00-11.50)
0.90 6 1.64
0.50 (5.00-1.50)
1.86 6 1.32
2.00 (1.00-4.00)
0.43 6 0.86
0.50 (1.00-2.00)
2.73 6 4.46
2.00 (6.00-11.00)
2.36 6 3.14
3.00 (3.50-8.00)
2.96 6 1.45
3.00 (6.00- 1.00)
7.06 6 3.86
7.50 (13.00-2.00)
5.40 6 4.03
4.50 (16.50-2.00)
1.93 6 2.35
2.50 (4.00-5.00)
0.60 6 1.12
0.50 (1.00-4.00)
0.33 6 0.72
0.50 (2.00-1.00)
0.26 6 0.62
0.00 (1.00-1.50)
0.53 6 0.85
0.00 (0.00-2.50)
0.33 6 0.44
0.00 (0.00-1.50)
0.90 6 1.15
0.50 (0.00-3.00)
0.80 6 1.85
0.00 (3.50-4.00)
0.13 6 0.63
0.00 (1.50-1.50)
0.43 6 1.51
0.00 (4.00-3.50)
0.83 6 1.43
0.50 (3.50-1.00)
0.20 6 0.64
0.00 (2.50-0.00)
0.00 6 0.00
0.00 (0.00-0.00)
1.66 6 3.79
2.00 (6.00-8.00)
2.43 6 2.08
2.00 (3.00-5.00)
3.36 6 1.20
3.50 (1.00-5.50)
2.86 6 1.88
2.50 (6.00-0.00)
3.43 6 1.76
3.00 (1.00-7.00)
1.33 6 2.12
1.00 (5.50-2.00)
2.66 6 2.34
2.00 (6.00-0.50)
NS
NS
*
*
NS
y
y
y
NS
NS
NS
y
y
y
y
*
y
3.86 6 2.59
4.00 (0.00-10.00)
3.86 6 2.23
4.00 (0.00-9.00)
2.66 6 2.17
2.00 (0.00-6.50)
2.90 6 3.29
2.50 (13.00-0.50)
2.63 6 2.74
2.00 (2.00-7.00)
1.16 6 2.41
1.00 (5.00-3.50)
2.53 6 2.23
3.00 (6.50-1.00)
NS
y
NS
*
*
y
y
y
*
*
y
y
y
y
y
NS
y
0.46 6 1.39
0.00 (2.00-4.00)
0.30 6 1.46
0.00 (2.00-3.00)
0.90 6 0.91
1.00 (1.00-2.50)
1.66 6 1.35
2.00 (0.50-4.00)
0.83 6 1.09
1.00 (1.00-3.00)
1.60 6 1.05
2.00 (0.00-3.50)
1.76 6 1.37
2.00 (0.50-4.00)
1-2
2-3
1-3
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
*
*
NS
NS
NS
Sar et al
647
Sar et al
648
2.
3.
4.
The maxilla was effectively protracted without signicant rotation in a shorter period of time in the
MP1FM group when compared with the FM group.
The mandible demonstrated signicantly greater
posterior rotation, and the increase in lower facial
height was more evident in the FM group.
The undesired dentoalveolar effects of conventional facemask therapies, such as mesialization
and proclination of the maxillary teeth and extrusion of the maxillary molars, were reduced or
eliminated with miniplate anchorage placed laterally to the apertura piriformis on both sides of the
maxilla.
Maxillary protraction via miniplate achorage might
be a promising early treatment approach in patients
with severe maxillary retrusion or a lack of anchorage teeth for a facemask. Future studies are needed
to examine the long-term stability of the changes
related to the maxilla and the mandible.
REFERENCES
1. Haynes S. The prevalence of malocclusion in English school children aged 11-12 years. Trans Eur Orthod Soc 1970;89-98.
2. Thilander B, Myberg N. The prevalence of malocclusion in Swedish
school children. Scand J Dent Res 1973;81:12-20.
3. Iwagaki H. Hereditary inuence of malocclusion. Am J Orthod Oral
Surg 1938;24:328-38.
4. Allwright WC, Burndred WH. A survey of handicapping dentofacial
anomalies among Chinese in Hong Kong. Int Dent J 1964;14:
505-19.
5. Irie M, Nakamura S. Orthopedic approach to severe skeletal Class III
malocclusion. Am J Orthod 1975;67:377-92.
6. Ellis EE, McNamara JA Jr. Components of adult Class III malocclusion. Am J Orthod 1984;85:277-90.
7. Nanda R. Biomechanical and clinical considerations of a modied
protraction headgear. Am J Orthod 1980;78:125-39.
8. Sanborn RT. Differences between the facial skeletal patterns of
Class III malocclusion and normal occlusion. Angle Orthod 1955;
25:208-22.
9. McNamara JA, Brudon WL. Orthodontic and orthopedic treatment
in the mixed dentition. Ann Arbor, Mich: Needham Press; 1993. p.
285-93.
10. Guyer EC, Ellis EE, McNamara JA Jr, Behrents RG. Components of
Class III malocclusion in juveniles and adolescents. Angle Orthod
1986;56:7-30.
Sar et al
649
40. Sung SJ, Baik HS. Assessment of skeletal and dental changes by
maxillary protraction. Am J Orthod Dentofacial Orthop 1998;
114:492-502.
41. McNamara JA. An orthopedic approach to the treatment of Class III
malocclusion in young patients. J Clin Orthod 1987;21:598-608.
42. Turley PK. Orthopedic correction of Class III malocclusion with palatal expansion and custom protraction headgear. J Clin Orthod
1988;22:314-25.
43. Haas J. Rapid expansion of the maxillary dental arch and nasal cavity
by opening the mid-palatal suture. Angle Orthod 1961;31:73-90.
44. Itoh T, Chaconas SJ, Caputo AA, Matyas J. Photoelastic effects of
maxillary protraction on the craniofacial complex. Am J Orthod
1985;88:117-24.
45. Ngan P, Hagg U, Yiu C, Merwin D, Wei SH. Soft tissue and dentoskeletal prole changes associated with maxillary expansion and
protraction headgear treatment. Am J Orthod Dentofacial Orthop
1996;109:38-49.
46. Tanne K, Hiraga J, Sakguda M. Effects of directions of maxillary
protraction forces on biomechanical changes in craniofacial complex. Eur J Orthod 1989;11:382-91.
47. Lee KG, Ryu YK, Park YC, Rudolph DJ. A study of holographic interferometry on the initial reaction of maxillofacial complex during
protraction. Am J Orthod Dentofacial Orthop 1997;111:623-32.
48. Mermigos J, Full CA, Andreasen G. Protraction of the maxillofacial
complex. Am J Orthod Dentofacial Orthop 1990;98:47-55.
49. Nartallo-Turley PE, Turley PK. Cephalometric effects of combined
palatal expansion and facemask therapy on Class III malocclusion.
Angle Orthod 1998;68:217-24.
50. Westwood PV, McNamara JA, Baccetti T, Franchi L, Sarver DM.
Long-term effects of Class III treatment with rapid maxillary expansion and facemask therapy followed by xed appliances. Am
J Orthod Dentofacial Orthop 2003;123:306-20.